Bain Capital Life Sciences Investors’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.59M | Hold |
|
|||||
|
2025
Q1 | $1.78M | Hold |
|
|||||
|
2024
Q4 | $4M | Hold |
|
|||||
|
2024
Q3 | $6.34M | Hold |
|
|||||
|
2024
Q2 | $5.14M | Sell |
|
|||||
|
2024
Q1 | $9.33M | Sell |
|
|||||
|
2023
Q4 | $9.28M | Hold |
|
|||||
|
2023
Q3 | $3.05M | Hold |
|
|||||
|
2023
Q2 | $4.52M | Hold |
|
|||||
|
2023
Q1 | $5.16M | Hold |
|
|||||
|
2022
Q4 | $9.69M | Hold |
|
|||||
|
2022
Q3 | $14.4M | Hold |
|
|||||
|
2022
Q2 | $12.4M | Hold |
|
|||||
|
2022
Q1 | $39.8M | Hold |
|
|||||
|
2021
Q4 | $52.9M | Buy |
|
|||||
|
2021
Q3 | $73.4M | Hold |
|
|||||
|
2021
Q2 | $62.1M | Hold |
|
|||||
|
2021
Q1 | $60.7M | Hold |
|
|||||
|
2020
Q4 | $54.4M | Buy |
|